Skip to main content
Surgical Case Reports
Fig. 4 | Surgical Case Reports

Fig. 4

From: Fatal acquired coagulation factor V deficiency after hepatectomy for advanced hepatocellular carcinoma as a possible immune checkpoint inhibitor-related adverse event: a case report

Fig. 4

Results of the Japanese Collaborative Research Group’s detailed experimental examination after the patient died. FV/5-specific (A) and FX/10-specific (B) cross-mixing tests measured residual FV/5 and FX/10 activities, respectively. Anti-FV/5 autoantibodies (C) and anti-FX/10 autoantibodies (D) were measured by in-house enzyme-linked immunosorbent assay using purified human FV/5 and FX/10, respectively, as previously described [9]

Back to article page